Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.41 USD
Change Today -0.02 / -0.21%
Volume 92.3K
BEAT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

biotelemetry inc (BEAT) Snapshot

Open
$9.53
Previous Close
$9.43
Day High
$9.53
Day Low
$9.26
52 Week High
01/13/15 - $11.33
52 Week Low
08/12/14 - $6.44
Market Cap
254.6M
Average Volume 10 Days
146.5K
EPS TTM
$0.25
Shares Outstanding
27.1M
EX-Date
--
P/E TM
37.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOTELEMETRY INC (BEAT)

Related News

No related news articles were found.

biotelemetry inc (BEAT) Related Businessweek News

No Related Businessweek News Found

biotelemetry inc (BEAT) Details

BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The Patient Services segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers Mobile Cardiac Outpatient Telemetry service, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter monitor to cardiologists and electrophysiologists. The Product segment focuses on the manufacture, engineering, and development of noninvasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors; and contract engineering and manufacturing services. The Research Services segment provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials to pharmaceutical companies, medical device companies, and contract research and academic research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, protocol development, imaging services, and expert reporting and statistical analysis. This segment also offers support services, such as project coordination, setup and management, equipment rental, data transfer, processing, and analysis, as well as 24/7 customer support and site training. The company is headquartered in Malvern, Pennsylvania.

922 Employees
Last Reported Date: 02/23/15

biotelemetry inc (BEAT) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $535.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $338.0K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $336.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $320.0K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $310.0K
Compensation as of Fiscal Year 2014.

biotelemetry inc (BEAT) Key Developments

BioTelemetry, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

BioTelemetry, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the period, the company’s revenue was $43.4 million compared to $37.2 million for the first quarter 2014, an increase of 17% or $6.2 million. Approximately half of the increase resulted from the full quarter impact of the Mednet and BMS acquisitions that occurred in the first and second quarters of 2014, respectively. On a GAAP basis, net loss was $0.1 million, or a loss of $0.00 per diluted share, compared to a net loss of $4.1 million, or a loss of $0.16 per diluted share, for the first quarter 2014. Excluding expenses related to integration, restructuring and other charges, adjusted net income was $1.8 million, or $0.06 per diluted share. This compares to an adjusted net loss of $0.9 million, or a loss of $0.04 per diluted share, for the first quarter 2014, which excludes the impact of integration, restructuring and other charges. Income from operations was $469,000 compared to loss from operations of $3,696,000 a year ago. Income before income taxes was $79,000 compared to loss before income taxes of $6,967,000 a year ago. Net cash used in operating activities was $4,606,000 compared to $2,060,000 a year ago. Capital expenditures were $2,072,000 compared to $3,859,000 a year ago. Adjusted EBITDA was $6,401,000 compared to $3,040,000 a year ago.

BioTelemetry, Inc. to Report Q1, 2015 Results on May 06, 2015

BioTelemetry, Inc. announced that they will report Q1, 2015 results at 4:00 PM, US Eastern Standard Time on May 06, 2015

BioTelemetry, Inc., Q1 2015 Earnings Call, May 06, 2015

BioTelemetry, Inc., Q1 2015 Earnings Call, May 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BEAT:US $9.41 USD -0.02

BEAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
LifeWatch AG SFr.16.70 CHF -0.05
SHL TeleMedicine Ltd SFr.9.80 CHF 0.00
View Industry Companies
 

Industry Analysis

BEAT

Industry Average

Valuation BEAT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTELEMETRY INC, please visit www.biotelinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.